查时间:肥胖个体HFpEF查的理由和路线图
相关实验视频
Updated: Sep 18, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
363
Anouk Achten1,2, Lukas Peeters3, Geert Verkoulen4
1Department of Cardiology, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM), PO Box 5800, 6202 AZ, Maastricht, The Netherlands. Anouk.achten@mumc.nl.
Heart failure reviews
|June 23, 2025
概括
肥胖症显著增加了心力衰竭与保留射出小部分 (HFpEF) 的风险,导致早期发病. 本综述主张对肥胖个体进行系统的HFpEF查,以便及时诊断和干预.
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 公共卫生 公共卫生
背景情况:
- 肥胖是心力衰竭的主要危险因素,常常导致疾病在十年内更早发病.
- 肥胖个体表现出独特的病理生理学特征,有助于HFpEF的发展.
- 目前的临床指南不建议在肥胖人群中进行系统的HFpEF查,尽管风险增加.
研究的目的:
- 审查在肥胖患者中实施HFpEF查的理由.
- 要突出与肥胖相关的HFpEF的日益增长的患病率,早期发病率和未被认可的临床表现.
- 在这个人口群体中提出针对HFpEF的量身定制的查和诊断途径.
主要方法:
- 讨论将肥胖与HFpEF (炎症,脂肪组织,血液动力学) 联系起来的病理生理机制.
- 对肥胖患者HFpEF目前的诊断局限性的批判性评估 (尿性,心声图).
- 评估现有和新兴的选工具,包括HFpEF-ABA评分.
主要成果:
- 肥胖加快了HFpEF的发病速度,并与特定的病理生理变化有关.
- 现有的诊断方法在肥胖个体中存在挑战.
- 建议采用针对肥胖患者的逐步查方法.
结论:
- 由于疾病负担较高和早期发病,在肥胖个体中对HFpEF进行系统查是有必要的.
- 通过查提前发现可能有助于及时进行干预.
- 需要进一步的前性研究来验证查的有效性,并确定肥胖人口中的HFpEF流行率.
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
209
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
209
01:24Obesity
627
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
627
01:22Heart Failure VI: Adjunct Therapies
39
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39